Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -103.29% is in line with its 5-year average of -110.70%, around the middle of its 5-year range (-338.39%–81.04%).
13.50% above its 12-month average of -119.41%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -133.10%.
NET PROFIT MARGIN
-103.29%
NET PROFIT MARGIN AVG TTM
-119.41%
NET PROFIT MARGIN AVG 3Y
-119.01%
NET PROFIT MARGIN AVG 5Y
-110.70%
NET PROFIT MARGIN AVG 10Y
-64.28%
NET PROFIT MARGIN AVG 15Y
-52.76%
NET PROFIT MARGIN AVG 20Y
-50.59%
CURRENT VS TTM AVG
+13.50%
CURRENT VS 3Y AVG
+13.21%
CURRENT VS 5Y AVG
+6.69%
CURRENT VS 10Y AVG
-60.68%
CURRENT VS 15Y AVG
-95.79%
CURRENT VS 20Y AVG
-104.16%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 636 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Standard BioTools Inc.
Market Cap
$292.42M
Net Profit Margin
-103.29%
TTM Avg
-119.41%
3Y Avg
-119.01%
5Y Avg
-110.70%
Market Cap
$293.99M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$290.35M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$286.40M
Net Profit Margin
-246.42%
TTM Avg
611.54%
3Y Avg
-783.13%
5Y Avg
-1134.34%
Market Cap
$283.44M
Net Profit Margin
0.00%
TTM Avg
-6.08%
3Y Avg
-1303.66%
5Y Avg
-1073.20%
Market Cap
$304.97M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-6520.67%
5Y Avg
-12425.66%
Market Cap
$278.45M
Net Profit Margin
-38.13%
TTM Avg
-18.76%
3Y Avg
-107.01%
5Y Avg
-249.44%
Market Cap
$310.71M
Net Profit Margin
-145.12%
TTM Avg
-145.12%
3Y Avg
-145.12%
5Y Avg
-145.12%
Market Cap
$275.74M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Standard BioTools Inc. (LAB) | $292.42M | -103.29% | -119.41% | -119.01% | -110.70% |
| BridgeBio Oncology Therapeutics Inc. (BBOT)vs › | $293.99M | 0.00% | 0.00% | 0.00% | 0.00% |
| Larimar Therapeutics, Inc. (LRMR)vs › | $290.35M | 0.00% | 0.00% | 0.00% | 0.00% |
| Abeona Therapeutics Inc. (ABEO)vs › | $286.40M | -246.42% | 611.54% | -783.13% | -1134.34% |
| Fulcrum Therapeutics, Inc. (FULC)vs › | $283.44M | 0.00% | -6.08% | -1303.66% | -1073.20% |
| Benitec Biopharma Inc. (BNTC)vs › | $304.97M | 0.00% | 0.00% | -6520.67% | -12425.66% |
| Aurora Cannabis Inc. (ACB)vs › | $278.45M | -38.13% | -18.76% | -107.01% | -249.44% |
| Mobia Medical, Inc. Common Stock (MOBI)vs › | $310.71M | -145.12% | -145.12% | -145.12% | -145.12% |
| Indaptus Therapeutics, Inc. (INDP)vs › | $275.74M | 0.00% | 0.00% | 0.00% | 0.00% |
| Fate Therapeutics, Inc. (FATE)vs › | $275.66M | -1941.09% | -1708.77% | -990.85% | -815.81% |
Operating Margin
-109.3%
Net Profit Margin
-103.3%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -133.10% |
| 2026-03-31 | -213.85% |
| 2025-12-31 | 81.04% |
| 2025-09-30 | -177.41% |
| 2025-06-30 | -153.75% |
| 2025-03-31 | -128.74% |
| 2024-12-31 | -72.93% |
| 2024-09-30 | -59.90% |
| 2024-06-30 | -203.26% |
| 2024-03-31 | -70.61% |
| 2023-12-31 | -70.16% |
| 2023-09-30 | -82.77% |
| 2023-06-30 | -61.59% |
| 2023-03-31 | -67.05% |
| 2022-12-31 | -77.14% |
| 2022-09-30 | -114.74% |
| 2022-06-30 | -338.39% |
| 2022-03-31 | -287.84% |
| 2021-12-31 | -24.64% |
| 2021-09-30 | -48.57% |
| 2021-06-30 | -55.27% |
| 2021-03-31 | -57.39% |
| 2020-12-31 | -40.41% |
| 2020-09-30 | -15.05% |
| 2020-06-30 | -49.95% |
| 2020-03-31 | -57.86% |
| 2019-12-31 | -39.10% |
| 2019-09-30 | -48.64% |
| 2019-06-30 | -48.78% |
| 2019-03-31 | -84.57% |
| 2018-12-31 | -45.71% |
| 2018-09-30 | -50.93% |
| 2018-06-30 | -61.45% |
| 2018-03-31 | -52.47% |
| 2017-12-31 | -37.69% |
| 2017-09-30 | -64.43% |
| 2017-06-30 | -70.81% |
| 2017-03-31 | -67.37% |
| 2016-12-31 | -70.55% |
| 2016-09-30 | -89.18% |
| 2016-06-30 | -66.09% |
| 2016-03-31 | -68.56% |
| 2015-12-31 | -41.92% |
| 2015-09-30 | -32.36% |
| 2015-06-30 | -53.24% |
| 2015-03-31 | -59.60% |
| 2014-12-31 | -32.68% |
| 2014-09-30 | -46.53% |
| 2014-06-30 | -45.94% |
| 2014-03-31 | -59.92% |
| 2013-12-31 | -18.86% |
| 2013-09-30 | -23.44% |
| 2013-06-30 | -23.15% |
| 2013-03-31 | -24.43% |
| 2012-12-31 | -23.00% |
| 2012-09-30 | -32.48% |
| 2012-06-30 | -35.37% |
| 2012-03-31 | -61.12% |
| 2011-12-31 | -26.60% |
| 2011-09-30 | -42.37% |
| 2011-06-30 | -67.95% |
| 2011-03-31 | -84.37% |
| 2010-12-31 | -29.72% |
| 2010-09-30 | -39.92% |
| 2010-06-30 | -60.06% |
| 2010-03-31 | -83.76% |
| 2009-12-31 | -44.97% |
| 2008-12-31 | 0.00% |
| 2008-06-30 | 0.00% |
| 2007-12-31 | 0.00% |
